Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

Clinical trial NCT00955682 · COMPLETED

Trial details

NCT number: NCT00955682
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Meningococcal

Start date: 2009-08-25
Primary completion: 2009-12-16
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.